Skip to main content
Erschienen in: BMC Medical Imaging 1/2022

Open Access 01.12.2022 | Research

Magnetic resonance imaging of parotid gland tumors: a pictorial essay

verfasst von: Soung Yung Kim, Urs Borner, Jung-Hyun Lee, Franca Wagner, Dechen W. Tshering Vogel

Erschienen in: BMC Medical Imaging | Ausgabe 1/2022

Abstract

Imaging of parotid gland tumors is challenging due to the wide variety of differential diagnoses. Malignant parotid tumors can have very similar features to benign ones, such as slow growth and displacement instead of infiltration of neighboring structures. Malignant and benign tumors may therefore not be clinically distinguishable. Correct characterization of parotid tumors (i.e., benign or malignant) determines preoperative treatment planning and is important in optimizing the individualized surgical plan. Magnetic resonance imaging (MRI) is the imaging modality of choice for evaluation of suspected parotid gland lesions and differentiation between benign and malignant lesions. Certain conventional MRI features can suggest whether a mass is more likely to be a benign or low-grade malignancy or a high-grade malignancy and adding diffusion-weighted imaging or advanced MRI techniques like perfusion can aid in this distinction. Morphological features seen on MRI, such as low signal on T2-w, infiltrative changes or ill-defined margins, change over time and diffusion restriction can point to the malignant nature of the lesion. MRI is useful for detection and localization of the lesion(s), and associated findings like perineural spread of tumor, lymph node involvement and infiltrative changes of the surrounding tissues. In this pictorial essay, we present selected images of a variety of benign and malignant parotid tumors and emphasize the MRI features that may be useful in their characterization.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Salivary gland tumors are rare, accounting for roughly 2–6.5% of all head and neck tumors and about 0.5% of all malignancies [13]. The most common location of salivary gland tumors is the parotid gland (70%), followed in descending order by the submandibular gland, the minor salivary glands, and the sublingual gland [3].
Parotid gland tumors are complex with a wide variety of histological types of benign and malignant lesions. Most of the parotid tumors in adults (about 80%) are benign, the most frequent being pleomorphic adenomas (about 65%) followed by Warthin’s tumors (about 15–20% of all parotid gland tumors) [4]. The most common malignant tumors are mucoepidermoid carcinomas, which account for 10% of salivary gland tumors and 30% of malignancies [4].
Preoperative characterization of parotid gland tumors using dedicated imaging is crucial for appropriate treatment planning, as the surgical approach is different for benign and malignant lesions and depends also on the localization of the tumor. Extracapsular dissection or partial parotidectomy is the surgical procedure of choice in patients with benign lesions. Patients with malignant tumors need more aggressive surgery (i.e., lateral, subtotal or total parotidectomy) with or without a neck dissection and potential sacrifice of the facial nerve [5]. Clinical assessments have limitations in diagnosing malignant parotid neoplasms and in most cases of palpable parotid masses, differentiation between benign and malignant lesions is not possible by clinical examination only. In addition, fine needle aspiration biopsy is sometimes inconclusive and may provide insufficient results.
Although ultrasound is also very useful for evaluation of parotid lesions, the deep lobe is not adequately seen using this technique. Therefore, magnetic resonance imaging (MRI) has assumed a major role in assessing lesions of the parotid gland. MRI can also provide more accurate information about the localization of the tumor either in the superficial or deep lobe. Although computed tomography (CT) can also provide this information, the better soft tissue resolution of MRI allows more accurate delineation of margins as well as tissue characterization. In this pictorial essay, we present images of a variety of benign and malignant parotid gland tumors and emphasize the MRI features that may be useful in their characterization and differentiation. The overview of the various figures is presented in Table 1.
Table 1
Overview of the images
Figure no
Benign lesions
Figure no
Malignant tumors
1
Pleomorphic adenoma
7
Mucoepidermoid carcinoma
2
Warthin’s tumor
8
Adenoid cystic carcinoma
3
Oncocytoma
9
Acinic cell carcinoma
4
Infantile hemangioma
10
Parotid carcinoma
5
Lipoma
11
Poorly differentiated carcinoma
6
Benign lymphoepithelial cyst
12
Lymphoma

Benign tumors

Pleomorphic adenomas

Pleomorphic adenoma (benign mixed tumor) is the most common benign parotid gland tumor in adults and predominates in females (2:1); it usually presents as a slowly growing, asymptomatic mass in a middle-aged patient. Pleomorphic adenoma has a tendency to degenerate, which is dependent on the age of the tumor [6].
The alternative term, benign mixed tumor, reflects the histological heterogeneity suggesting a variety of imaging findings [5]. The imaging appearances vary depending on tumor size. Small tumors are more homogeneous and well defined, with strong enhancement following administration of intravenous contrast medium. Larger tumors tend to have pedunculated outgrowth from the main lesion (lobulated contour) and are more heterogeneous, with necrotic and hemorrhagic areas [5]. In general, however, the pleomorphic adenoma has very high signal on T2-weighted (T2-w) images, higher than the cerebrospinal fluid signal (Fig. 1) with higher apparent diffusion coefficient (ADC) values. Dystrophic calcification is highly suggestive of this tumor but cannot be visualized or distinguished from focal areas of fibrosis on MRI [7].
There are three malignancies associated with pleomorphic adenoma: (1) the carcinoma ex pleomorphic adenoma; (2) the true malignant mixed tumor (carcinosarcoma); and (3) the metastasizing ´benign’ mixed tumor. The carcinoma ex pleomorphic adenoma is a malignant change of a benign mixed tumor or a malignant tumor in a patient who has previously undergone surgical tumor resection for a pleomorphic adenoma. The true malignant mixed tumor (carcinosarcoma) is a rare entity with a poor prognosis. The metastasizing ‘benign’ mixed tumor is the rarest variant. Metastases may be multiple and occur in the lung, bone and soft tissue, often over decades [5].

Warthin’s tumor

Warthin’s tumor, also known as cystadenolymphoma, is the second most common benign tumor of the parotid gland. It is the most common neoplasm that manifests as multiple lesions and is bilateral in up to 10–20% of cases [5, 8]. It often presents as a slowly growing painless mass in older men and has a strong association with smoking [9].
Warthin’s tumors are seen in imaging exams as well-encapsulated, partly cystic, partly solid lesions, often located in the parotid tail. On MRI, Warthin’s tumors show a low to intermediate T1-w signal intensity with cysts containing cholesterol components appearing as focal areas of high signal intensity [10]. On T2-w images, Warthin’s tumors are heterogeneous with variable signal intensity. After contrast medium administration, the solid components of the tumor can enhance minimally (Fig. 2). Warthin’s tumors are also often picked up incidentally during 18F-fluorodeoxyglucose positron emission tomography CT (18F-FDG PET/CT) scans as they take up glucose [11] (Fig. 2).

Oncocytoma

Parotid gland oncocytoma is a rare benign epithelial tumor that accounts for less than 1% of all salivary gland tumors [8, 1214]. The most common clinical presentation is a painless, slow-growing, non-tender, lobulated, and mobile mass. Parotid gland oncocytomas can occasionally (< 10%) be multifocal or bilateral [13].
On MRI examination, oncocytomas are generally hypointense on T1-w images, isointense to hypointense on T2-w images and isointense on T1-w fat-saturated images (Fig. 3). They are also metabolically active and can show avid uptake of glucose on PET scans [14]. Oncocytomas tend to have higher ADC values due to lower diffusion restriction than in Warthin’s tumor and this can help in differentiating between these two tumors.

Infantile hemangioma

Parotid infantile hemangiomas are the most common benign parotid tumor in children with a predominance in females of 3:1 [15]. Hemangiomas manifest shortly after birth as unilateral parotid swelling. They show rapid enlargement in infancy, which is normally followed by gradual regression starting at 8–18 months of age [14]. They can occasionally act as significant vascular shunts if they do not involute.
On MRI, parotid infantile hemangiomas are isointense to muscle on T1-w images and hyperintense on T2-w images. After contrast medium administration, there is homogeneous contrast enhancement with the presence of characteristic flow voids in or around the mass, due to prominent vasculature [5] (Fig. 4).

Lipoma

Parotid lipomas are uncommon, well-circumscribed, benign non-epithelial neoplasms. They may be located with the gland itself or may be extracapsular within the adjacent parotid space [16]. They show the characteristic signal of fat-containing lesions on MRI [17]. Typical signal intensities isointense to fat on all pulse sequences are visible on MRI (Fig. 5). It is important to differentiate lipomas from other lipomatous lesions of the parotid gland, such as liposarcoma.

Tumor-like lesions: benign lymphoepithelial lesions

Benign lymphoepithelial lesions are caused by reactive lymphoid infiltrate with follicular hyperplasia, which leads to proliferation and disruption of ductal epithelium and obliteration of the acinar glandular tissue [18]. They are normally seen in people with Sjögren’s syndrome in the context of lymphoepithelial sialadenitis or HIV infection [19]. On imaging, numerous entirely cystic, combined cystic and solid, or entirely solid lesions, which can be either bilateral or unilateral, are observed in the parotid gland [20].
Sporadic or simple lymphoepithelial cysts (LECs) of the parotid gland are not associated with HIV or Sjögren’s syndrome. They are predominantly unilocular, unilateral, solitary and well circumscribed [20, 21].
On MRI, LECs of the parotid gland are usually well-circumscribed cystic spaces and may demonstrate thin rim enhancement following contrast administration (Fig. 6). Other cystic lesions in the parotid gland, such as first branchial cleft cysts (FBCC), salivary duct cysts and sialoceles can look similar. Differentiation on MRI is possible if additional features can be identified.
FBCCs in the parotid gland can present as a cystic mass adjacent to the external auditory canal. They are usually well defined, unilocular or multilocular, oval or round and thin-walled in the absence of complications like infections or bleeding. They can be difficult to differentiate from LECs: the presence of fistulas and sinuses points to a diagnosis of FBCC [20].
Salivary duct cysts can be seen in the superficial lobe of the parotid gland. These are considered to be true cysts and can be congenital or acquired. They are painless, unilateral swellings which are compressible. They appear similar to the LECs but may occasionally have fluid-fluid levels and mural nodules [20].
A sialocele has been described as an accumulation of extravasated saliva in the surrounding tissue secondary to excretory duct obstruction following trauma or surgery. MRI shows well-defined cystic lesions, but the signal intensity of the fluid can vary according to the mucin content of the sialocele [20].

Malignant tumors

Malignant tumors include primary parotid malignancies, which are a very heterogeneous group of carcinomas (World Health Organization classification from 2017 lists more than 20 entities of salivary carcinomas). Here we present images of mucoepidermoid carcinoma, adenoid cystic carcinoma, acinic cell carcinoma and parotid carcinoma (Figs. 7, 8, 9, 10, 11). Metastases can also be difficult to differentiate from primary parotid malignancies. It is often not possible to determine the specific histology of parotid tumors solely on the basis of their MRI appearances, but certain findings are indicative of malignancy. An aggressive parotid tumor typically shows low signal intensity on T2-w images and an ill-defined tumor margin with an infiltrative border after contrast administration [22]. Irregular margins and invasion into the adjacent structures can indicate the presence of an infiltrating malignant parotid tumor. The clinical sign that a parotid neoplasm is malignant is facial nerve palsy.

Mucoepidermoid carcinoma

Mucoepidermoid carcinomas (MEC) are the most common malignant parotid tumors in both children and adults [5, 23]. They most frequently arise in the parotid gland (about 50%), and present as a painless swelling, with or without facial nerve involvement. They often have a cystic component due to their mucin content.
MECs are believed to arise from the pluripotent reserve cells of the excretory ducts and they comprise three different cell types, mucinous, intermediate and epidermoid. Grading reportedly corresponds with the clinical behavior of the tumor. Previous irradiation in the area is a risk factor.
The imaging features depend on the histological type. On MRI, low-grade tumors are well circumscribed with a signal intensity similar to that of pleomorphic adenomas. High-grade tumors, on the other hand, have infiltrating margins with heterogeneous low to intermediate signal intensities on both T1-w and T2-w images (Fig. 7). MECs may show homogeneous or heterogeneous enhancement after contrast administration. Low-grade MECs usually have hyperintense areas on T2-w images, reflecting a cystic architectural pattern due to existence of mucous producing cells. Although some literature describes ill-defined margins as a predictor of high-grade malignancy they can also reflect peritumoral inflammatory change [24].

Adenoid cystic carcinoma

Adenoid cystic carcinomas (ACCs) are the second most common malignancy of the parotid gland and account for 2–6% of all parotid gland tumors. These tumors arise more often in the minor salivary glands (about 55%) than in the parotid glands. They have the greatest propensity for perineural spread (via cranial nerve VII) and local invasion [25]. Therefore, it is essential to image the facial nerves to assess for perineural spread along the course of the nerve into the mastoid segment of the temporal bone.
On MRI, ACCs are hypointense to isointense on T1-w images and slightly hyperintense on T2-w images with strong enhancement after contrast medium administration (Fig. 8).

Acinic cell carcinoma

Acinic cell carcinomas of the salivary glands are rare malignant tumors and account for only 2–5% of the primary parotid gland malignancies [26]. They are located almost exclusively in the parotid gland (81–98%) [27] and commonly arise in the parotid tail. They can be bilateral and multifocal. Acinic cell carcinomas are usually painless and slowly growing masses.
On MRI, acinic cell carcinomas usually have non-specific imaging features (Fig. 9), similar to benign tumors such as pleomorphic adenoma or to low‑grade malignant tumors. Therefore, tissue sampling is often required for pathological assessment to establish an accurate diagnosis.

High-grade carcinoma and poorly differentiated carcinoma

Signs suggesting high-grade malignancies include low to intermediate signal intensity on T2-w, which reflects high cellularity, ill-defined margins reflecting the invasive growth of tumor cells, and frequent nodal involvement reflecting the propensity for lymphatic involvement [22]. Perineural spread is also well seen on MRI and radiological findings include obliteration of fat planes at foramina openings, thickening and increased enhancement of the nerve, and enhancement and muscle changes (Figs. 10, 11).

Carcinoma ex pleomorphic adenoma

Carcinoma ex pleomorphic adenoma arises from a preexisting pleomorphic adenoma or recurrent benign pleomorphic adenoma. The typical clinical presentation in patients (usually in their 6th–8th decade) with carcinoma ex pleomorphic adenoma is a longstanding history (typically 10–15 years) of pleomorphic adenoma and a sudden period of rapid growth (average, 3–6 months) [28].
On MRI, new aggressive infiltrative margins and rapid enlargement of a preexisting pleomorphic adenoma are features highly suggestive of malignant transformation. Carcinoma ex pleomorphic adenomas are generally heterogeneous on T1-w images due to hemorrhage, necrosis and calcification and are also generally hypointense on T2-w images [28]. They tend to have low ADC values compared to pleomorphic adenomas, which typically have higher values.

Lymphoma

Primary lymphoma in a salivary gland is rare and accounts for 4.7% of lymphomas at all sites [29]. Non-Hodgkin lymphoma (NHL) presenting in the salivary glands is the most commonly seen lymphoma type and arises within the parotid gland in 75% of cases. The most common subtypes of NHL are extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type, follicular B-cell lymphoma and diffuse large B-cell lymphoma. The MALT subtype is more common in a parotid gland. Sjögren syndrome is considered a risk factor [30].
Lymphomas generally have low signal intensity on T1-w images and low to high signal intensity on T2-w images, with variable enhancement following contrast administration [31]. Because lymphomas are highly cellular tumors, water diffusion is restricted, making them appear hyperintense on diffusion-weighted imaging (DWI) and hypointense on ADC maps (Fig. 12).

Metastasis

Metastases of other primary tumors in the salivary glands are relatively rare, but are most commonly seen in the parotid gland. Metastatic involvement of the parotid gland is typically due to cutaneous squamous cell carcinoma and melanoma [32, 33]. The major mechanism of metastasis is via lymphatic spread to intraparotid lymph nodes due to the intense drainage through lymph vessels and the presence of many lymph nodes in the parotid gland. Thus, identification of abnormal‑appearing intraparotid lymph nodes using imaging techniques has important therapeutic and prognostic significance in patients with such cancers.
On MRI, presentation of metastases to intraparotid lymph nodes is similar to metastatic lymph nodes elsewhere in the head and neck area. Progressive enlargement, central necrosis, and ill‑defined margins are all imaging features suggestive of lymphatic metastasis [8]. When large, these look like malignant primary tumors of the parotid gland.

Advances in MRI technologies: perfusion MRI and radiomics

Dynamic contrast-enhanced (DCE)-MRI provides biomarkers of tissue perfusion with proven utility in oncologic imaging and has been shown to improve distinction of parotid gland tumors [34, 35]. Dynamic contrast-enhanced perfusion MRI, also known as permeability imaging, measures the T1 signal before, during, and after contrast administration and a time–intensity curve is generated from which a transfer constant can be calculated [36]. Four distinct time–intensity curve patterns have been described based on wash-in, wash-out, and time to peak contrast enhancement. Pleomorphic adenomas usually show gradual enhancement. Both malignant tumors and Warthin’s tumors show mostly rapid enhancement, but Warthin’s tumors show a higher wash-out ratio than do malignant tumors [37].
Radiomics is the process of extracting quantitative data from medical images using data characterization algorithms [38]. This is an innovative field in oncological imaging and has also been applied to parotid lesions [39]. The authors performed a retrospective evaluation of the T2 images of parotid lesions from 75 patients. After the regions of interest had been manually drawn, texture analysis was performed with the QUIBIM Precision Platform (QUIBIM SL, Valencia, Spain), which automatically generated 29 quantitative radiomic features including a gray-level histogram and a co-occurrence matrix analysis. The quantitative data were displayed visually using a boxplot, and the unpaired two-sample Wilcoxon rank-sum test was used to find the MRI textural features that could help in the differentiation of benign from malignant tumors, pleomorphic adenoma from Warthin tumor and Warthin tumors from malignant tumors. Receiver operating characteristics curve analyses were done to find the threshold values for the most discriminative features. The results showed that radiomic features based on a histogram and gray-level co-occurrence matrix helped to differentiate between benign and malignant parotid gland tumors, pleomorphic adenomas and malignant parotid tumors and between pleomorphic adenomas and Warthin tumors using the T2-w images. Warthin tumors, however, could not be differentiated from malignant tumors using these parameters [39].

Conclusions

Certain conventional MRI features can suggest whether a mass is more likely to be a benign or low-grade malignancy or a high-grade malignancy, and adding DWI or advanced MRI techniques like perfusion can aid in this distinction. MRI morphological features such as low signal on T2-w, infiltrative changes or ill-defined margins, changes over time and diffusion restriction can point to the malignant nature of the lesion.
MRI is useful for detection of a lesion or lesions, the localization of the lesion and other associated findings like perineural spread of tumor, lymph node involvement and infiltrative changes of the surrounding tissues. Advanced technologies like dynamic contrat-enhanced perfusion MRI and radiomics show promising results in differentiation of certain pathologies.
However, there are still many lesions that require a fine needle puncture or biopsy for confirmation of the diagnosis. We hope that the examples presented in this pictorial essay will contribute to making the evaluation of these lesions easier.

Acknowledgements

We especially thank Mrs. Susan Kaplan for language support.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
10.
Zurück zum Zitat Minami M, Tanioka H, Oyama K, Itai Y, Eguchi M, Yoshikawa K, et al. Warthin tumor of the parotid gland: MR-pathologic correlation. AJNR Am J Neuroradiol. 1993;14(1):209–14.PubMedPubMedCentral Minami M, Tanioka H, Oyama K, Itai Y, Eguchi M, Yoshikawa K, et al. Warthin tumor of the parotid gland: MR-pathologic correlation. AJNR Am J Neuroradiol. 1993;14(1):209–14.PubMedPubMedCentral
12.
Zurück zum Zitat Barnes LEJ, Reichart P. Oncocytoma. In: Barnes LEJ, Reichart P, Sidransky D, editors. World Health Organization classification of tumors: pathology and genetics, head and neck tumors. Lyon: IARC Press; 2005. p. 242–3. Barnes LEJ, Reichart P. Oncocytoma. In: Barnes LEJ, Reichart P, Sidransky D, editors. World Health Organization classification of tumors: pathology and genetics, head and neck tumors. Lyon: IARC Press; 2005. p. 242–3.
18.
Zurück zum Zitat Orell SR, Klijanienko J. Head and neck; salivary glands. In: Orell SR, Sterrett GF, editors. Orell and Sterrett’s fine needle aspiration cytology. 5th ed. London: Churchill Livingstone; 2012. p. 38–76.CrossRef Orell SR, Klijanienko J. Head and neck; salivary glands. In: Orell SR, Sterrett GF, editors. Orell and Sterrett’s fine needle aspiration cytology. 5th ed. London: Churchill Livingstone; 2012. p. 38–76.CrossRef
19.
Zurück zum Zitat Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal. 2007;12(7):E479–85.PubMed Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal. 2007;12(7):E479–85.PubMed
26.
Zurück zum Zitat Rosero DS, Alvarez R, Gambó P, Alastuey M, Valero A, Torrecilla N, et al. Acinic cell carcinoma of the parotid gland with four morphological features. Iran J Pathol. 2016;11(2):181–5.PubMedPubMedCentral Rosero DS, Alvarez R, Gambó P, Alastuey M, Valero A, Torrecilla N, et al. Acinic cell carcinoma of the parotid gland with four morphological features. Iran J Pathol. 2016;11(2):181–5.PubMedPubMedCentral
27.
Zurück zum Zitat Vidyadhara S, Shetty AP, Rajasekaran S. Widespread metastases from acinic cell carcinoma of parotid gland. Singapore Med J. 2007;48(1):e13–5.PubMed Vidyadhara S, Shetty AP, Rajasekaran S. Widespread metastases from acinic cell carcinoma of parotid gland. Singapore Med J. 2007;48(1):e13–5.PubMed
Metadaten
Titel
Magnetic resonance imaging of parotid gland tumors: a pictorial essay
verfasst von
Soung Yung Kim
Urs Borner
Jung-Hyun Lee
Franca Wagner
Dechen W. Tshering Vogel
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Medical Imaging / Ausgabe 1/2022
Elektronische ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-022-00924-0

Weitere Artikel der Ausgabe 1/2022

BMC Medical Imaging 1/2022 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.